NCT00193466View on ClinicalTrials.gov

Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2007

Study Completion Date

April 30, 2008

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG

Rituximab

DRUG

Fludarabine

DRUG

CAMPTH-1H

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER